Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $89 | $92 | $656 | $620 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $82 | $129 | $115 | $114 |
| Inventory | $0 | $0 | $1 | $0 |
| Other Curr. Assets | $12 | $12 | $8 | $11 |
| Total Curr. Assets | $182 | $233 | $781 | $745 |
| Property Plant & Equip (Net) | $16 | $18 | $20 | $23 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3 | $4 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $15 | $0 |
| Tax Assets | $144 | $212 | $284 | $0 |
| Other NC Assets | $6 | $4 | $1 | $359 |
| Total NC Assets | $169 | $238 | $320 | $382 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $351 | $471 | $1,101 | $1,127 |
| Liabilities | – | – | – | – |
| Payables | $2 | $8 | $0 | $1 |
| Short-Term Debt | $3 | $203 | $3 | $120 |
| Tax Payable | $1 | $1 | $1 | $0 |
| Deferred Revenue | $2 | $3 | $0 | $0 |
| Other Curr. Liab. | $31 | $62 | $21 | $41 |
| Total Curr. Liab. | $39 | $276 | $26 | $162 |
| LT Debt | $596 | $513 | $413 | $356 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $17 | $28 | $10 | $4 |
| Total NC Liab. | $613 | $541 | $423 | $359 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $15 | $18 | $20 | $22 |
| Total Liabilities | $652 | $817 | $448 | $521 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,698 | -$1,699 | -$696 | -$938 |
| AOCI | $1 | -$3 | $0 | -$0 |
| Other Equity | $1,395 | $1,355 | $1,349 | $1,543 |
| Total Equity | -$301 | -$346 | $652 | $606 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $351 | $471 | $1,101 | $1,127 |
| Net Debt | $511 | $623 | -$240 | -$144 |